The Depletion of NAMPT Disturbs Mitochondrial Homeostasis and Causes Neuronal Degeneration in Mouse Hippocampus - PubMed (original) (raw)
. 2023 Mar;60(3):1267-1280.
doi: 10.1007/s12035-022-03142-5. Epub 2022 Nov 28.
Affiliations
- PMID: 36441480
- DOI: 10.1007/s12035-022-03142-5
The Depletion of NAMPT Disturbs Mitochondrial Homeostasis and Causes Neuronal Degeneration in Mouse Hippocampus
Chen Shen et al. Mol Neurobiol. 2023 Mar.
Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) is the key enzyme in the salvaging synthesis pathway of the nicotinamide adenine dinucleotide (NAD). Both NAMPT and NAD progressively decline upon aging and neurodegenerative diseases. The depletion of NAMPT induces mitochondrial dysfunction in motor neurons and causes bioenergetic stress in neurons. However, the roles of NAMPT in hippocampus neurons need to be further studied. Using floxed Nampt (Namptflox/flox) mice, we knocked out Nampt specifically in the hippocampus CA1 neurons by injecting rAAV-hSyn-Cre-APRE-pA. The depletion of NAMPT in hippocampus neurons induced cognitive deficiency in mice. Nevertheless, no morphological change of hippocampus neurons was observed with immunofluorescent imaging. Under the transmission electron microscope, we observed mitochondrial swollen and mitochondrial number decreasing in the cell body and the neurites of hippocampus neurons. In addition, we found the intracellular Aβ (6E10) increased in the hippocampus CA1 region. The intensity of Aβ42 remained unchanged, but it tended to aggregate. The GFAP level, an astrocyte marker, and the Iba1 level, a microglia marker, significantly increased in the mouse hippocampus. In the primary cultured rat neurons, NAMPT inhibition by FK866 decreased the NAD level of neurons at > 10-9 M. FK866 dropped the mitochondrial membrane potential in the cell body of neurons at > 10-9 M and in the dendrite of neurons at > 10-8 M. FK866 decreased the number and shortened the length of branches of neurons at > 10-7 M. Together, likely due to the injury of mitochondria, the decline of NAMPT level can be a critical risk factor for neurodegeneration.
Keywords: Mitochondria homeostasis; NAD (nicotinamide adenine dinucleotide); NAMPT (nicotinamide phosphoribosyltransferase); Neurodegeneration.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
- NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
Zhang XQ, Lu JT, Jiang WX, Lu YB, Wu M, Wei EQ, Zhang WP, Tang C. Zhang XQ, et al. Neuroscience. 2015 Apr 16;291:230-40. doi: 10.1016/j.neuroscience.2015.02.007. Epub 2015 Feb 12. Neuroscience. 2015. PMID: 25684751 - Effect of alternating nicotinamide phosphoribosyltransferase expression levels on mitophagy in Alzheimer's disease mouse models.
Zhao N, Xu B, Xia J, Wang J, Zhang X, Yan Q. Zhao N, et al. Biochim Biophys Acta Mol Basis Dis. 2024 Oct;1870(7):167288. doi: 10.1016/j.bbadis.2024.167288. Epub 2024 Jun 9. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38862096 - Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.
Liu LY, Wang F, Zhang XY, Huang P, Lu YB, Wei EQ, Zhang WP. Liu LY, et al. PLoS One. 2012;7(10):e44933. doi: 10.1371/journal.pone.0044933. Epub 2012 Oct 11. PLoS One. 2012. PMID: 23071504 Free PMC article. - Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.
Wang SN, Xu TY, Li WL, Miao CY. Wang SN, et al. CNS Neurosci Ther. 2016 Jun;22(6):431-9. doi: 10.1111/cns.12539. Epub 2016 Mar 28. CNS Neurosci Ther. 2016. PMID: 27018006 Free PMC article. Review. - Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
Griffiths HBS, Williams C, King SJ, Allison SJ. Griffiths HBS, et al. Biochem Soc Trans. 2020 Jun 30;48(3):733-744. doi: 10.1042/BST20190033. Biochem Soc Trans. 2020. PMID: 32573651 Review.
Cited by
- Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function.
Su M, Qiu F, Li Y, Che T, Li N, Zhang S. Su M, et al. Front Cell Dev Biol. 2024 Sep 20;12:1464815. doi: 10.3389/fcell.2024.1464815. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39372950 Free PMC article. Review. - Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
Chen Y, Wang T, Liang F, Han J, Lou Z, Yu Y, Li J, Zhan T, Gu Y, Dong L, Jiang B, Zhang W, Wu M, Lu Y. Chen Y, et al. Theranostics. 2024 Apr 28;14(7):2794-2815. doi: 10.7150/thno.94482. eCollection 2024. Theranostics. 2024. PMID: 38773984 Free PMC article. - Transcriptome- and proteome-wide effects of a circular RNA encompassing four early exons of the spinal muscular atrophy genes.
Luo D, Ottesen EW, Lee JH, Singh RN. Luo D, et al. Sci Rep. 2024 May 7;14(1):10442. doi: 10.1038/s41598-024-60593-7. Sci Rep. 2024. PMID: 38714739 Free PMC article. - Transcriptome- and proteome-wide effects of a circular RNA encompassing four early exons of the spinal muscular atrophy genes.
Luo D, Ottesen E, Lee JH, Singh R. Luo D, et al. Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3818622. doi: 10.21203/rs.3.rs-3818622/v1. Res Sq. 2024. PMID: 38464174 Free PMC article. Updated. Preprint. - Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease.
Feuz MB, Meyer-Ficca ML, Meyer RG. Feuz MB, et al. Cells. 2023 Feb 3;12(3):500. doi: 10.3390/cells12030500. Cells. 2023. PMID: 36766842 Free PMC article. Review.
References
- Zeng K, Yu X, Mahaman YAR, Wang JZ, Liu R, Li Y, Wang X (2022) Defective mitophagy and the etiopathogenesis of Alzheimer’s disease. Transl Neurodegener 11:32. https://doi.org/10.1186/s40035-022-00305-1 - DOI
- Yaku K, Okabe K, Nakagawa T (2018) NAD metabolism: implications in aging and longevity. Ageing Res Rev 47:1–17. https://doi.org/10.1016/j.arr.2018.05.006 - DOI
- Okabe K, Yaku K, Tobe K, Nakagawa T (2019) Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci 26:34. https://doi.org/10.1186/s12929-019-0527-8 - DOI
- Clement J, Wong M, Poljak A, Sachdev P, Braidy N (2019) The plasma NAD(+) metabolome is dysregulated in “normal” aging. Rejuvenation Res 22:121–130. https://doi.org/10.1089/rej.2018.2077 - DOI
- Ralto KM, Rhee EP, Parikh SM (2020) NAD(+) homeostasis in renal health and disease. Nat Rev Nephrol 16:99–111. https://doi.org/10.1038/s41581-019-0216-6 - DOI
MeSH terms
Substances
Grants and funding
- 2018YFA0507700/National Key R&D Program of China
- 81971304/National Natural Science Foundation of China
- 81573400/National Natural Science Foundation of China
- LY18H170001/Natural Science Foundation of Hebei Province
- LZ20H010001/Natural Science Foundation of Hebei Province
LinkOut - more resources
Full Text Sources
Miscellaneous